Loading organizations...
Nedermaas Hightech Ventures operates as a venture capital firm, specializing in pre-seed and seed stage investments for high-tech companies. The firm targets innovative startups and small to medium-sized enterprises across life science, healthcare, chemical, and material sectors. It provides capital and guidance to foster development and scaling of promising technologies, primarily within the Limburg region.
Established as the Nedermaas Ventures fund in 2010, the firm was managed by LIOF Nedermaas High Tech Ventures, indicating ties to regional development. Its inception stems from an identified need for dedicated early-stage capital to cultivate Limburg's high-tech ecosystem, stimulating local innovation and economic growth. While individual founders are not detailed, the fund fills a crucial market gap.
The firm’s portfolio companies are early-stage high-tech ventures based in or committed to the Limburg region of the Netherlands. Nedermaas Hightech Ventures empowers these entrepreneurs, facilitating progression of groundbreaking technologies. Its vision centers on developing a robust high-tech landscape, addressing industrial and societal challenges through sustained innovation.
Nedermaas Hightech Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $2.9M Series A in BioActor in July 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 26, 2011 | BioActor | $2.9M Series A | — | Hans VAN DER Saag, ICOS Capital, Limburg Ventures |
| May 1, 2011 | Q Chip | $6.0M Series C | Limburg Ventures, Nedermaas Hightech Ventures | Brightlands Venture Partners, JON Moulton, KEN Powell, SIR Harry Solomon, Development Bank OF Wales, Disruptive Capital Finance |